Analysts expect over 2018 rising revenue Coloplast

Tomorrow the Danish company Coloplast will publish its past quarters results. For this year Coloplast's revenue will be around 17,94 billion Danish Krone. This is according to the average of the analysts' estimates. This is slightly more than 2017's revenue of 16,45 billion Danish Krone.

Historical revenues and results Coloplast plus estimates 2018

The analysts expect for 2018 a net profit of 4,24 billion Danish Krone. Most of the analysts anticipate on a profit per share of 20 Danish Krone. The PE-ratio therefore is 30,19.

For this year the analysts expect a dividend of 17,09 Danish Krone per share. The dividend yield is then 2,83 percent. The average dividend yield of the pharmaceutical companies is a low 1 percent.

Coloplast's market capitalization is based on the number of outstanding shares around 117,25 billion Danish Krone. The Coloplast stock was the past 12 months quite volatile. Since last February the stock is even 24 percent higher. This year the stock price moved between 474 and 717 DKK. Since 2008 the stock price is almost 692 percent higher.

Historical stock prices Coloplast

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.